PADI3 and infection: While our research does not directly link this phenotype with the modification of specific proteins involved in antiviral responses or restriction activity, given the very narrow PAD3 expression spectrum in human tissues and its high specificity of induction during HSV-1 and HSV-2 infections, it is tempting to speculate that PAD3-specific inhibitors may be suitable candidates for treating these infections.